Andrew Allen, Gritstone CEO (Gritstone via website)
August 17, 2021 07:29 AM EDTUpdated 10:35 AM
Coronavirus

Covid-19 roundup: CEPI in­jects $20.6M in­to Grit­stone's push for a next-gen vac­cine; Quali­gen shelves its Covid-19 can­di­date af­ter a failed IND

Nicole DeFeudis

Editor

As the Delta vari­ant dri­ves a glob­al surge in Covid-19 cas­es, the Coali­tion for Epi­dem­ic Pre­pared­ness In­no­va­tions (CEPI) is in­vest­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Among phar­ma CEOs, the IRA now and the IRA lat­er get very dif­fer­ent re­ac­tions

Bris­tol My­ers restarts ra­dio­phar­ma­ceu­ti­cal Phase 3 tri­al, but de­lays read­out by one year

An­drew Left, short sell­er who cam­paigned against Valeant, is ac­cused of fraud by SEC

Up­dat­ed: With cost-cut­ting un­der­way, Bris­tol My­ers rais­es guid­ance, touts Phase 3 win and scraps an­oth­er

Eu­ro­pean drug reg­u­la­tor re­jects Alzheimer's drug Leqem­bi, cit­ing safe­ty con­cerns

sponsored

Crit­i­cal Junc­tures in Gene Ther­a­py Clin­i­cal Ma­te­r­i­al Man­u­fac­tur­ing: Where Do I Start? And Will It Work?

A service from the Financial Times